Skip to content

Asset Entities ASST Medical Device — Income tax expense (benefit)

Other segment segments

Asset Management
$0
Corporate & Other
$0

Similar metrics at other companies

Glaukos logo
GKOSDevelopment And Commercialization Of Ophthalmic Therapies — Income Tax Expense Benefit
$484K+48.5%
Berkshire Hathaway logo
BRK.AManufacturing Businesses — Income Tax Expense Benefit
$716M+17.2%
PTC Therapeutics logo
PTCTLife Science — Income Tax Expense Benefit
$347K-99.5%
Chevron logo
CVXAll Other — Income Tax Expense (Benefit)
-$158M-295%
Freedom Holding logo
FRHCInsurance — Income Tax Expense (Benefit)
$1.1M
AMP
AMPHPharmaceutical Products — Income Tax Expense Benefit
$3.63M-34.9%

Other financials

Income statement

See full
Revenue$2.8M+1,516%
Operating income-$313.1M-7,588%
Net income-$265.9M-6,993%
EPS (diluted)-$4.53-175%

Balance sheet

See full
Cash & equivalents$95.1M+982%
Total debt$3.4M
Total equity$714.8M+3,548%
Total assets$1.1B+21,931%

Cash flow

See full
Operating cash flow-$31.0M-455%
CapEx--100%
Free cash flow-$31.0M-450%

Valuation

See full
Market cap$1.02B+1,127%
Enterprise value$932M
P/S118.1×

Profitability

See full
Operating margin-6,563%-18,545pp
Net margin-8,022.9%-20,291pp
FCF margin-3,856.7%

Returns & leverage

See full
Return on equity-189.4%+139pp
Debt / equity
Current ratio11.4×+1.7×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Asset Entities's medical device — income tax expense (benefit).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Asset Entities's medical device — income tax expense (benefit)?
Asset Entities (ASST) reported medical device — income tax expense (benefit) of $0 in Q1 2026.
What does medical device — income tax expense (benefit) mean?
Reflects the total tax impact, whether an expense or a benefit, attributable to the medical device segment's earnings. Understanding this figure is crucial for calculating the segment's effective tax rate and its contribution to the company's net income.